Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Multiple Myeloma 3Melanoma 3Lung Neoplasms 3Recurrence 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neuroblastoma 2Neoplasms 2Glioblastoma 2Wilms Tumor 1Uterine Neoplasms 1Urogenital Neoplasms 1Triple Negative Breast Neoplasms 1Thoracic Neoplasms 1Stomach Neoplasms 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Pinealoma 1Ovarian Neoplasms 1Osteosarcoma 1Neuroectodermal Tumors, Primitive 1Neoplasms by Site 1Meningeal Neoplasms 1

Interventions

patritumab deruxtecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer × 1 year × Clear all
NCT06099639 2025-06-08

Medical Access Program for Patritumab Deruxtecan

Daiichi Sankyo

No longer available
Thoracic

Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡